Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2026-01-19 @ 11:41 AM
Study NCT ID:
NCT02012959
Status:
TERMINATED
Last Update Posted:
2018-09-26
First Post:
2013-12-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
156-08-276
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |